ANIXA BIOSCIENCES INC EBITDA 2010-2022 | ANIX
ANIXA BIOSCIENCES INC ebitda from 2010 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
ANIXA BIOSCIENCES INC Annual EBITDA
(Millions of US $) |
| 2021 |
$-13 |
| 2020 |
$-10 |
| 2019 |
$-11 |
| 2018 |
$-14 |
| 2017 |
$-6 |
| 2016 |
$-4 |
| 2015 |
$-0 |
| 2014 |
$-4 |
| 2013 |
$-7 |
| 2012 |
$-4 |
| 2011 |
$-5 |
| 2010 |
$-5 |
| 2009 |
$-7 |
ANIXA BIOSCIENCES INC Quarterly EBITDA
(Millions of US $) |
| 2022-01-31 |
$-4 |
| 2021-10-31 |
$-4 |
| 2021-07-31 |
$-4 |
| 2021-04-30 |
$-2 |
| 2021-01-31 |
$-2 |
| 2020-10-31 |
$-2 |
| 2020-07-31 |
$-2 |
| 2020-04-30 |
$-3 |
| 2020-01-31 |
$-3 |
| 2019-10-31 |
$-2 |
| 2019-07-31 |
$-2 |
| 2019-04-30 |
$-2 |
| 2019-01-31 |
$-5 |
| 2018-10-31 |
$-5 |
| 2018-07-31 |
$-6 |
| 2018-04-30 |
$-1 |
| 2018-01-31 |
$-2 |
| 2017-10-31 |
$-2 |
| 2017-07-31 |
$-2 |
| 2017-04-30 |
$-1 |
| 2017-01-31 |
$-1 |
| 2016-10-31 |
$-1 |
| 2016-07-31 |
$-1 |
| 2016-04-30 |
$-1 |
| 2016-01-31 |
$-1 |
| 2015-10-31 |
$-1 |
| 2015-07-31 |
$-1 |
| 2015-04-30 |
$-2 |
| 2015-01-31 |
$4 |
| 2014-10-31 |
$-1 |
| 2014-07-31 |
$0 |
| 2014-04-30 |
$-1 |
| 2014-01-31 |
$-2 |
| 2013-10-31 |
$-2 |
| 2013-07-31 |
$-2 |
| 2013-04-30 |
$-1 |
| 2013-01-31 |
$-2 |
| 2012-10-31 |
$-2 |
| 2012-07-31 |
$-1 |
| 2012-04-30 |
$-1 |
| 2012-01-31 |
$-1 |
| 2011-10-31 |
$-1 |
| 2011-07-31 |
$-1 |
| 2011-04-30 |
$-1 |
| 2011-01-31 |
$-2 |
| 2010-10-31 |
$-1 |
| 2010-07-31 |
$-1 |
| 2010-04-30 |
$-1 |
| 2010-01-31 |
$-2 |
| 2009-10-31 |
$-3 |
| 2009-07-31 |
$-1 |
| 2009-04-30 |
$-1 |
| 2009-01-31 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.099B |
$0.001B |
|
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
|
